Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Utility of a mainstreamed genetic testing pathway in breast and ovarian cancer patients during the COVID-19 pandemic.

European journal of medical genetics - 1 Dec 2020

Benusiglio Patrick R, Korenbaum Clément, Vibert Roseline, Ezenfis Joël, Geoffron Sophie, Paul Charlotte, Richard Sandrine, Byrde Veronique, Lejeune Manon, Guillerm Erell, Basset Noemie, Lotz Jean-Pierre, Chabbert-Buffet Nathalie, Gligorov Joseph, Coulet Florence

Abstract excerpt

INTRODUCTION: Mainstreamed genetic testing (MGT) obviates the need for a cancer genetics consultation, since trained oncologists (O) and gynaecologists (G) provide counseling, prescribe testing and deliver results. We report results from our MGT program and emphasize its utility during the COVID-19 lockdown, when cancer genetics clinics had suspended their activity. METHODS: An MGT pathway for breast and ovarian...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to BRCA2 Protein
Share to Fanconi Anemia Complementation Group N Protein

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hereditary Breast and Ovarian Cancer Syndrome

Share to Mastectomy

Share to Neoadjuvant Therapy

Share to Pandemics

Share to Salpingo-oophorectomy

Source

Open in PubMed Open full text

Identifiers

PMID: 33186762
DOI: 10.1016/j.ejmg.2020.104098
PMCID: PMC7654320

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Utility of a mainstreamed genetic testing pathway in breast and ovarian cancer patients during the COVID-19 pandemic.PMID 33186762Read ↗

BRCA testing in a genomic diagnostics referral center during the COVID-19 pandemic.Semantic proximity Read ↗

Clinical Utility of Universal Germline Genetic Testing for Patients With Breast Cancer.Semantic proximity Read ↗

Results of breast cancer risk assessment and hereditary cancer genetic testing in community obstetrics and gynaecology practice following a prospective quality Improvement initiative.Semantic proximity Read ↗

Re-evaluating hereditary breast and ovarian cancer risk: clinical impact of updated multigene panel sequencing and genetic counseling.Semantic proximity Read ↗

Routine germline genetic testing in 3552 unselected NHS breast cancer patients: Evidence informing testing criteria and implementation of a ‘BRCA-DIRECT’ mainstreaming pathwaySemantic proximity Read ↗

Quality of care before and after initial certification at a German certified hereditary breast and ovarian cancer centerSemantic proximity Read ↗

Universal Genetic Testing for Newly Diagnosed Invasive Breast Cancer.Semantic proximity Read ↗

Breast cancer multigene germline panel testing in mainstream oncology based on clinical-public health utility (cancer mortality benefit): ESMO Precision Oncology Working Group recommendationsSemantic proximity Read ↗

The Clinical and Genetic Landscape of Hereditary Cancer: Experience from a Single Clinical Diagnostic Laboratory.Semantic proximity Read ↗

Breast cancer germline multigene panel testing in mainstream oncology based on clinical–public health utility: ESMO Precision Oncology Working Group recommendationsSemantic proximity Read ↗

Disparities in Genetic Management of Breast and Ovarian Cancer Patients.Semantic proximity Read ↗

Exploring the hereditary genetic mutational landscape of breast and ovarian cancer in Estonia.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.